Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

PMX-53

Home DrugsPMX-53

PMX-53

Unknown Manufacturer

Generate AI report

Share to Twitter Share to Facebook Share to LinkedIn Share to Reddit

Patents

One entry per invention. Patent families filed in the US, EP, WO and CN offices.

PMX‑53明胶复合微粒及其制备方法
Applicant: 吉林大学Priority: 2015
CN
Application of PMX-53 polypeptide in preparation of medicine for treating non-alcoholic steatohepatitis
Applicant: FIRST AUXILIARY HOSPITAL OF GUANGXI MEDICAL UNIVPriority: 2022
CN
PMX-53 nano drug-loaded particle and application thereof in treatment of thoracic aortic diseases
Applicant: UNIV SOOCHOWPriority: 2026
CN
Application of small molecule compound PMX 53 in preparation of medicine for inhibiting vascular calcification and vascular fibrosis
Applicant: THE 8TH AFFILIATED HOSPITAL OF SUN YAT SEN UNIV SHENZHEN FUTIANPriority: 2023
CN